Skip to main content
Erschienen in: Pediatric Radiology 6/2010

01.06.2010 | Review

Vascular anomalies: what a radiologist needs to know

verfasst von: Josée Dubois, Marianne Alison

Erschienen in: Pediatric Radiology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Most haemangiomas and vascular malformations are identified according to clinical criteria. A good knowledge of the classification and clinical characteristics of the vascular anomalies is necessary when managing these patients. However, some cases are challenging either because of an atypical presentation (e.g., soft-tissue mass with normal overlying skin) or because of classification difficulties. Doppler US and MRI are the two main imaging modalities that allow classification of the vascular anomalies and are useful in those clinically uncertain cases to establish the correct diagnosis. This aids the choice of the most appropriate treatment and to inform the parents of the prognosis. High-resolution grey-scale and Doppler US allow excellent visualization of most superficial masses. Doppler US is the easiest way to assess the haemodynamics of a vascular lesion and to clarify a doubtful diagnosis between a haemangioma and vascular malformation. MRI is the best technique for evaluating the extent of the lesions and their relationship to adjacent structures. While newly developed drugs from angiogenesis research labs are awaited, radiologists have an important role in the treatment of haemangiomas and vascular malformations. Intervention remains crucial in cases of alarming haemangiomas and venous malformations (VM), lymphatic malformations (LM) and arteriovenous malformations (AVM). A multidisciplinary team, including paediatricians, haematologists, surgeons and radiologists, must manage the problem cases both in terms of diagnostic work-up and therapeutic options. This paper will briefly discuss the imaging findings and treatment of vascular anomalies.
Literatur
1.
Zurück zum Zitat Mulliken JB, Glowacki J (1982) Classification of pediatric vascular lesions. Plast Reconstr Surg 70:120–121CrossRefPubMed Mulliken JB, Glowacki J (1982) Classification of pediatric vascular lesions. Plast Reconstr Surg 70:120–121CrossRefPubMed
2.
3.
Zurück zum Zitat Dubois J, Patriquin HB, Garel L et al (1998) Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR 171:247–252PubMed Dubois J, Patriquin HB, Garel L et al (1998) Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR 171:247–252PubMed
4.
Zurück zum Zitat Konez O, Burrows PE (2002) Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 10:363–388CrossRefPubMed Konez O, Burrows PE (2002) Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 10:363–388CrossRefPubMed
5.
Zurück zum Zitat Metry DW, Hawrot A, Altman C et al (2004) Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 140:591–596CrossRefPubMed Metry DW, Hawrot A, Altman C et al (2004) Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 140:591–596CrossRefPubMed
6.
Zurück zum Zitat Metry DW, Dowd CF, Barkovich AJ et al (2001) The many faces of PHACE syndrome. J Pediatr 139:117–123CrossRefPubMed Metry DW, Dowd CF, Barkovich AJ et al (2001) The many faces of PHACE syndrome. J Pediatr 139:117–123CrossRefPubMed
7.
Zurück zum Zitat Léauté-Labrèze C, Taïeb A (2008) Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol 135:860–862CrossRefPubMed Léauté-Labrèze C, Taïeb A (2008) Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol 135:860–862CrossRefPubMed
8.
Zurück zum Zitat Boon LM, Enjolras O, Mulliken JB (1996) Congenital hemangioma: evidence of accelerated involution. J Pediatr 128:329–335CrossRefPubMed Boon LM, Enjolras O, Mulliken JB (1996) Congenital hemangioma: evidence of accelerated involution. J Pediatr 128:329–335CrossRefPubMed
9.
Zurück zum Zitat North PE, Waner M, James CA et al (2001) Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 137:1607–1620PubMed North PE, Waner M, James CA et al (2001) Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 137:1607–1620PubMed
10.
Zurück zum Zitat Dubois J, Garel L, David M et al (2002) Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. AJR 178:1541–1545PubMed Dubois J, Garel L, David M et al (2002) Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. AJR 178:1541–1545PubMed
11.
Zurück zum Zitat Robertson RL, Robson CD, Barnes PD et al (1999) Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am 9:115–132PubMed Robertson RL, Robson CD, Barnes PD et al (1999) Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am 9:115–132PubMed
12.
Zurück zum Zitat Trop I, Dubois J, Guibaud L et al (1999) Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 212:841–845PubMed Trop I, Dubois J, Guibaud L et al (1999) Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 212:841–845PubMed
13.
Zurück zum Zitat Paltiel HJ, Burrows PE, Kozakewich HP et al (2000) Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214:747–754PubMed Paltiel HJ, Burrows PE, Kozakewich HP et al (2000) Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214:747–754PubMed
14.
Zurück zum Zitat Siegel MJ (2001) Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 39:701–720CrossRefPubMed Siegel MJ (2001) Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 39:701–720CrossRefPubMed
15.
Zurück zum Zitat Li W, David V, Kaplan R et al (1998) Three-dimensional low dose gadolinium-enhanced peripheral MR venography. J Magn Reson Imaging 8:630–633CrossRefPubMed Li W, David V, Kaplan R et al (1998) Three-dimensional low dose gadolinium-enhanced peripheral MR venography. J Magn Reson Imaging 8:630–633CrossRefPubMed
16.
Zurück zum Zitat Dubois J, Garel L, Abela A et al (1997) Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 204:651–654PubMed Dubois J, Garel L, Abela A et al (1997) Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 204:651–654PubMed
17.
Zurück zum Zitat Molitch HI, Unger EC, Witte CL et al (1995) Percutaneous sclerotherapy of lymphangiomas. Radiology 194:343–347PubMed Molitch HI, Unger EC, Witte CL et al (1995) Percutaneous sclerotherapy of lymphangiomas. Radiology 194:343–347PubMed
18.
Zurück zum Zitat Ogita S, Tsuto T, Nakamura K et al (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784–785CrossRefPubMed Ogita S, Tsuto T, Nakamura K et al (1994) OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784–785CrossRefPubMed
19.
Zurück zum Zitat Baskin D, Tander B, Bankaoğlu M (2005) Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg 15:383–386CrossRefPubMed Baskin D, Tander B, Bankaoğlu M (2005) Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg 15:383–386CrossRefPubMed
20.
Zurück zum Zitat Muir T, Kirsten M, Fourie P et al (2004) Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 19:766–773CrossRefPubMed Muir T, Kirsten M, Fourie P et al (2004) Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 19:766–773CrossRefPubMed
21.
Zurück zum Zitat Orford J, Barker A, Thonell S et al (1995) Bleomycin therapy for cystic hygroma. J Pediatr Surg 30:1282–1287CrossRefPubMed Orford J, Barker A, Thonell S et al (1995) Bleomycin therapy for cystic hygroma. J Pediatr Surg 30:1282–1287CrossRefPubMed
22.
Zurück zum Zitat Zhong PQ, Zhi FX, Li R et al (1998) Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:139–144CrossRefPubMed Zhong PQ, Zhi FX, Li R et al (1998) Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:139–144CrossRefPubMed
23.
Zurück zum Zitat Zulfiqar MA, Zaleha AM, Zakaria Z et al (1999) The treatment of neck lymphangioma with intralesional injection of bleomycin. Med J Malaysia 54:478–481PubMed Zulfiqar MA, Zaleha AM, Zakaria Z et al (1999) The treatment of neck lymphangioma with intralesional injection of bleomycin. Med J Malaysia 54:478–481PubMed
24.
Zurück zum Zitat Sanlialp I, Karnak I, Tanyel FC et al (2003) Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 67:795–800CrossRefPubMed Sanlialp I, Karnak I, Tanyel FC et al (2003) Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 67:795–800CrossRefPubMed
25.
Zurück zum Zitat Sung MW, Lee DW, Kim DY et al (2001) Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 111:1430–1433CrossRefPubMed Sung MW, Lee DW, Kim DY et al (2001) Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 111:1430–1433CrossRefPubMed
26.
Zurück zum Zitat Alqahtani A, Nguyen LT, Flageole H et al (1999) 25 years’ experience with lymphangiomas in children. J Pediatr Surg 34:1164–1168CrossRefPubMed Alqahtani A, Nguyen LT, Flageole H et al (1999) 25 years’ experience with lymphangiomas in children. J Pediatr Surg 34:1164–1168CrossRefPubMed
27.
Zurück zum Zitat Enjolras O, Riche MC, Merland JJ (1985) Facial port-wine stains and Sturge-Weber syndrome. Pediatrics 76:48–51PubMed Enjolras O, Riche MC, Merland JJ (1985) Facial port-wine stains and Sturge-Weber syndrome. Pediatrics 76:48–51PubMed
28.
Zurück zum Zitat Jacob AG, Driscoll DJ, Shaughnessy WJ et al (1998) Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc 73:28–36CrossRefPubMed Jacob AG, Driscoll DJ, Shaughnessy WJ et al (1998) Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc 73:28–36CrossRefPubMed
29.
Zurück zum Zitat Gloviczki P, Driscoll DJ (2007) Klippel-Trenaunay syndrome: current management. Phlebology 22:291–298CrossRefPubMed Gloviczki P, Driscoll DJ (2007) Klippel-Trenaunay syndrome: current management. Phlebology 22:291–298CrossRefPubMed
31.
Zurück zum Zitat Moodley M, Ramdial P (1993) Blue rubber bleb nevus syndrome: case report and review of the literature. Pediatrics 92:160–162PubMed Moodley M, Ramdial P (1993) Blue rubber bleb nevus syndrome: case report and review of the literature. Pediatrics 92:160–162PubMed
32.
33.
Zurück zum Zitat Esterly NB (1996) Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 26:3–39CrossRefPubMed Esterly NB (1996) Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 26:3–39CrossRefPubMed
34.
Zurück zum Zitat Wiedemann HR, Burgio GR (1986) Encephalocraniocutaneous lipomatosis and Proteus syndrome. Am J Med Genet 25:403–404CrossRefPubMed Wiedemann HR, Burgio GR (1986) Encephalocraniocutaneous lipomatosis and Proteus syndrome. Am J Med Genet 25:403–404CrossRefPubMed
35.
Zurück zum Zitat Clark RD, Donnai D, Rogers J et al (1987) Proteus syndrome: an expanded phenotype. Am J Med Genet 27:99–117CrossRefPubMed Clark RD, Donnai D, Rogers J et al (1987) Proteus syndrome: an expanded phenotype. Am J Med Genet 27:99–117CrossRefPubMed
36.
38.
Zurück zum Zitat Garzon MC, Huang JT, Enjolras O et al (2007) Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56:541–564CrossRefPubMed Garzon MC, Huang JT, Enjolras O et al (2007) Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56:541–564CrossRefPubMed
39.
Zurück zum Zitat Hovius SE, Borg DH, Paans PR et al (1996) The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study. Ann Plast Surg 37:278–285CrossRefPubMed Hovius SE, Borg DH, Paans PR et al (1996) The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study. Ann Plast Surg 37:278–285CrossRefPubMed
40.
Zurück zum Zitat Taschner CA, Gieseke J, Le Thuc V et al (2008) Intracranial arteriovenous malformation: time-resolved contrast-enhanced MR angiography with combination of parallel imaging, keyhole acquisition, and k-space sampling techniques at 1.5 T. Radiology 246:871–879CrossRefPubMed Taschner CA, Gieseke J, Le Thuc V et al (2008) Intracranial arteriovenous malformation: time-resolved contrast-enhanced MR angiography with combination of parallel imaging, keyhole acquisition, and k-space sampling techniques at 1.5 T. Radiology 246:871–879CrossRefPubMed
41.
Zurück zum Zitat Reinacher PC, Stracke P, Reinges MH et al (2007) Contrast-enhanced time-resolved 3-D MRA: applications in neurosurgery and interventional neuroradiology. Neuroradiology 49:S3–S13CrossRefPubMed Reinacher PC, Stracke P, Reinges MH et al (2007) Contrast-enhanced time-resolved 3-D MRA: applications in neurosurgery and interventional neuroradiology. Neuroradiology 49:S3–S13CrossRefPubMed
42.
Zurück zum Zitat Saleh RS, Lohan DG, Villablanca JP et al (2008) Assessment of craniospinal arteriovenous malformations at 3 T with highly temporally and highly spatially resolved contrast-enhanced MR angiography. AJNR 29:1024–1031CrossRefPubMed Saleh RS, Lohan DG, Villablanca JP et al (2008) Assessment of craniospinal arteriovenous malformations at 3 T with highly temporally and highly spatially resolved contrast-enhanced MR angiography. AJNR 29:1024–1031CrossRefPubMed
43.
Zurück zum Zitat Wu Y, Kim N, Korosec FR et al (2007) 3D time-resolved contrast-enhanced cerebrovascular MR angiography with subsecond frame update times using radial k-space trajectories and highly constrained projection reconstruction. AJNR 28:2001–2004CrossRefPubMed Wu Y, Kim N, Korosec FR et al (2007) 3D time-resolved contrast-enhanced cerebrovascular MR angiography with subsecond frame update times using radial k-space trajectories and highly constrained projection reconstruction. AJNR 28:2001–2004CrossRefPubMed
44.
Zurück zum Zitat Ziyeh S, Strecker R, Berlis A et al (2005) Dynamic 3D MR angiography of intra- and extracranial vascular malformations at 3 T: a technical note. AJNR 26:630–634PubMed Ziyeh S, Strecker R, Berlis A et al (2005) Dynamic 3D MR angiography of intra- and extracranial vascular malformations at 3 T: a technical note. AJNR 26:630–634PubMed
45.
Zurück zum Zitat Enjolras O (1997) Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol 24:701–710PubMed Enjolras O (1997) Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol 24:701–710PubMed
46.
Zurück zum Zitat Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924CrossRefPubMed Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924CrossRefPubMed
47.
Metadaten
Titel
Vascular anomalies: what a radiologist needs to know
verfasst von
Josée Dubois
Marianne Alison
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Radiology / Ausgabe 6/2010
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-010-1621-y

Weitere Artikel der Ausgabe 6/2010

Pediatric Radiology 6/2010 Zur Ausgabe

ESPR Abstracts 2010

Oral presentations

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.